 CAMBRIDGE, Mass., Jan. 05, 2021 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that the company will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021. 